scholarly article | Q13442814 |
P50 | author | William B. Kannel | Q15439387 |
Emelia J. Benjamin | Q28754501 | ||
Ramachandran S. Vasan | Q30348351 | ||
Michael J Pencina | Q37382178 | ||
Philimon Gona | Q38625598 | ||
Ralph B. D'Agostino Sr. | Q59209521 | ||
Thomas J. Wang | Q80460150 | ||
Daniel Levy | Q88264418 | ||
Raghava S Velagaleti | Q114308524 | ||
Jayashri R Aragam | Q114427805 | ||
P2093 | author name string | Douglas S Lee | |
P2860 | cites work | Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community | Q33659377 |
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study | Q34140511 | ||
The Natural History of Congestive Heart Failure: The Framingham Study | Q34701680 | ||
Wall stress and patterns of hypertrophy in the human left ventricle | Q35194096 | ||
The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study | Q37252005 | ||
Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study) | Q37269763 | ||
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study | Q37385696 | ||
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute | Q37417065 | ||
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements | Q39605651 | ||
A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload | Q43519443 | ||
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study | Q46056330 | ||
Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). | Q46587540 | ||
Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) Study: clinical correlates and influences on systolic and diastolic dysfunction | Q46606495 | ||
Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study | Q48491751 | ||
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. | Q50957875 | ||
Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. | Q51896569 | ||
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. | Q52429603 | ||
Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension | Q52455174 | ||
Surgical ventricular restoration in patients with ischemic dilated cardiomyopathy: Evaluation of systolic and diastolic ventricular function, wall stress, dyssynchrony, and mechanical efficiency by pressure-volume loops | Q57298877 | ||
Prognosis of left ventricular geometric patterns in the Framingham heart study | Q57740676 | ||
An investigation of coronary heart disease in families. The Framingham offspring study | Q59461737 | ||
Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction | Q62818473 | ||
M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study) | Q73870544 | ||
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? | Q74364485 | ||
Device-based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy | Q74486719 | ||
Epidemiological approaches to heart disease: the Framingham Study | Q75689289 | ||
Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction | Q79393159 | ||
Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients | Q79749033 | ||
Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle | Q80055213 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart failure | Q181754 |
ejection fraction | Q641303 | ||
left ventricular hypertrophy | Q1628627 | ||
P304 | page(s) | 117-122 | |
P577 | publication date | 2013-10-04 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction | |
P478 | volume | 113 |
Q55279096 | "Frailty, thy name is woman": syndrome of women with heart failure with preserved ejection fraction. |
Q38764956 | Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine |
Q36046811 | Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population |
Q33732380 | Alterations in cardiac structure and function in hypertension |
Q38893111 | Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients |
Q46310992 | An exploratory investigation of echocardiographic parameters and the effects of posture on cardiac structure and function in the Livingstone's fruit bat (Pteropus livingstonii). |
Q36074394 | Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population. |
Q30692600 | Cardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring Study |
Q38726519 | Dietary management of heart failure: room for improvement? |
Q89674863 | Do We Need to Know the Left Ventricular Geometry Patterns of the Brazilian Population? |
Q37219607 | ECG low QRS voltage and wide QRS complex predictive of centenarian 360-day mortality |
Q53590491 | Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction. |
Q57308303 | Epidemiology of heart failure with preserved ejection fraction |
Q58127115 | Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA |
Q40296294 | Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study |
Q64100032 | Galectin-3 Is Associated With Stage B Metabolic Heart Disease and Pulmonary Hypertension in Young Obese Patients |
Q37637447 | Heart Failure in Women--Insights from the Framingham Heart Study |
Q26747554 | Heart Failure with Preserved Ejection Fraction - Concept, Pathophysiology, Diagnosis and Challenges for Treatment |
Q28066310 | Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus |
Q47179239 | Impact of echocardiography on one-month and one-year mortality of intertrochanteric fracture patients |
Q38209968 | Myocardial remodeling in hypertension |
Q89523491 | Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy |
Q30384457 | Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation. |
Q88747990 | Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF |
Q91037375 | Recent advances in understanding the roles of T cells in pressure overload-induced cardiac hypertrophy and remodeling |
Q60922030 | Role of spironolactone in the treatment of heart failure with preserved ejection fraction |
Q35548448 | The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling |
Search more.